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Abstract. There is evidence that hormone regulation of 
cellular oncogenes plays an essential role in human cancer. 
The c-H-ras gene is implicated through both mutation and 
abnormal gene expression in many types of human cancer. 
Computer scanning of this gene has revealed two putative 
hormone response motifs: A possible Glucocorticoid 
Response Element (GRE) at position 1261 of the first intron 
of the H-rasl gene and a putative Estrogen Response 
Element (ERE), at position 3007 of the fourth intron of the 
gene. In DNA binding assays, using the HeLa and LATK~ 
cell lines, we showed specific binding of the corresponding 
receptors at both putative Η-ras glucocorticoid and estrogen 
response sequences, suggesting that hormones could be 
contributing to Η-ras transcriptional regulation through 
interaction with their corresponding Hormone Response 
Elements (HREs). 
Introduction 
Nuclear receptors, such as those for steroid/thyroid 
hormones, vitamin D, and retinoic acid, are known to act as 
gene regulators, controlling the transcription of target genes 
by binding to cis-acting DNA elements referred to as 
hormone responsive elements (HREs) (reviewed in ref. 1). 
Negative HREs, which repress expression of specific genes, 
have been characterized (2,3), however, the mechanism of 
their action is still poorly understood. Consensus steroid 
hormone REs correspond to palindromic sequences (4,5), 
however, either imperfect palindromic HREs (6,7) or their 
interference with other as-acting regulatory elements (8,9) or 
factors (10), may also generate efficient HREs. 
Glucocorticoids regulate transcription of a number of 
genes by the direct interaction of the hormone receptor 
complex with GREs. GREs contain an imperfect palindromic 
consensus sequence 5'-GGTACANNNTGTTCT-3', (1) with 
highly conserved TGTTCT oligonucleotide and quite 
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variable upstream hexanucleotide (11,12). Interference 
between the glucocorticoid receptor and other transcription 
factors has also been shown (13,14). The hormone response 
elements in the conserved 5'-AGGTCANNNTGACCT-3' 
sequence is the ERE consensus oligonucleotide (5). 
Additionally, 5'-TGACCT-3' half palindromic oligo­
nucleotides may act synergistically conferring estrogen 
response to a gene, even at a long distance from the gene 
promoter (15,16), possibly through estrogen receptor-
associated proteins (17). GREs and EREs have been 
identified and characterized in a number of cellular genes 
(18-21), as well as in viral regulatory regions (22-25), but 
little is known about the presense of glucocorticoid and 
estrogen response elements in cellular oncogenes. 
The Η-ras gene, a member of the ras family of proto-
oncogenes, is readily implicated in many types of human 
cancer both through mutation (26) and abnormal gene 
expression and is involved in multiple signal transduction 
pathways, under normal cellular growth as well (27). The 
fact that overexpression of ras genes may cause oncogenic 
transformation (28,29) and that expression of the normal H-ras 
gene can act as an onco-supressor (30), indicate the 
importance of understanding the way ras genes are regulated. 
Elevated expression of the ras genes has also been found in a 
variety of human tumors (for a review see ref. 31). 
Considering the possible role of hormonal steroids as 
tumor promoters (32), we computer scanned the human c-H-
ras\ sequence for potential hormone response elements. We 
observed a putative GRE motif with 100% similarity in the 
half palindrome consensus oligonucleotide at position 1261 
(GGCCAGACCTGTTCT) of the conserved 3' end of the first 
intron (33) and a possible ERE motif, with 90% similarity, at 
position 3007 (GGGCCACCCTGACCT) of the fourth intron 
of the Η-ras gene. Using gel retardation experiments with 
nuclear extracts from HeLa and LATK" cell lines, which 
possess hormone receptors, we showed that both 
glucocorticoid and estrogen receptors bind their cognate 
oligonucleotides of Η-ras in a specific way, thus suggesting a 
role for glucocorticoids and estrogens in regulation of the H-ras 
gene expression. 
Materials and methods 
Cells and culture conditions. Human cervical epithelial 
tumor cells (HeLa) and tumor mouse fibroblasts (LATK ) 
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E R E CONSENSUS 
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Figure I. Organization of the human c-H-rasl gene-sequences and positions 
of the Η-ras glucocorticoid responce element-(GRE) and estrogen response 
element (ERE). Some possible regulatory elements in the vicinity of the 
Η-ras GRE are also shown. The coding sequences are represented by black 
boxes, the untranslated sequences by open boxes, the VTR by a crosshatched 
box and the regulatory elements by shadowed boxes. The direction of 
transcription is indicated by arrows. Asterisks indicate homology between 
hormone response elements and the corresponding consensus 
oligonucleotides. 
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Figure 2. Sequence specific binding of GR to the H-ras GRE. Binding 
reaction mixtures contained 15 μg of HeLa total nuclear protein, 0.01 
pmoles of v3!P-end labelled probes hMTIIA GRE (lanes 1-7) and RAS GRE 
(lanes 8-12) and a 150 fold molar excess over the labelled probe of the 
unlabelled competitor oligonucleotide (lanes 2-6 and 8-12). Protein-DNA 
complexes were separated by Polyacrylamide gel electrophoresis and 
visualized by autoradiography. GR-RAS GRE complex is indicated by the 
HeLa and LATK" nuclear extacts were used as a source of GR. 
Fig. 2 shows the interaction of GR and H-ras GRE. The 
labelled hMTIIA GRE and RAS GRE probes were incubated 
with HeLa nuclear extract in the absence (lanes 1,7) or 
presence of unlabelled oligonucleotide competitors. The 
labelled probes were competed for protein binding with a 
molar excess of unlabelled oligonucleotides: (lanes 2,8), with 
each other (lanes 3,9) and with the unrelated SP-1 (lanes 
4,10), NF-1 (lanes 5,11 ) and HIV-1LTR AP-1 (lanes 6,12). A 
common retarded band was seen in lanes 1 and 7, indicating 
the presence of a GR-DNA complex. Binding of GR on RAS 
GRE probe was abolished in the presence of excess of GRE 
containing competitors, but was unaffected by the other 
competitors such as SP-1, NF-1 or HIV-1 LTR-AP-1. An 
equivalent picture resulted from the hMTIIA GRE probe. 
Fig. 2 showed a strong sequence specificity of a protein for 
the H-ras DNA target and suggested that this protein was the 
GR, as it was shown by the common band in lanes 1 and 7 
and was displaced only by GRE-related competitors. 
A further, more direct demonstration of the GR-H-ras 
GRE interaction is shown in Fig. 3. «P-labelled RAS GRE 
probe was incubated with HeLa nuclear protein, in the 
absence (lane 3), or presence (lanes 4-6) of increasing 
amounts of polyclonal anti-human glucocorticoid receptor 
antibody. Control hMTIIA GRE probe was also incubated, in 
the absence (lane 1) or presence (lane 2) of polyclonal anti-
human GR antibody. Inclusion of the antibody into the 
reaction mixture led to the disappearance of the specific 
retarded band, clearly indicating that this was due to GR-
DNA interaction. 
The hMTIIA GRE and RAS GRE radiolabeled probes 
were incubated with increasing amounts of GR-containing 
HeLa (lanes 6-11) and LATK" (lanes 1-5) extracts (Fig. 4). A 
retarded band was seen and a stronger GR-DNA complex 
was observed, in both cell lines, with increasing amount of 
nuclear extract. 
RAS ERE probe, encompassing the H-ras ERE sequence 
and Vitellogenin ERE probe, encompassing the estrogen 
response sequence from Xenopus Vitellogenin A2 gene were 
used for ER binding experiments. The labelled Vitellogenin 
ERE and RAS ERE probes were incubated with HeLa 
nuclear extract in the absence (lanes 1,5) or presence of an 
excess of unlabelled oligonucleotide competitors (Fig. 5). 
The labelled probes were competed for protein binding with 
related (lanes 2,6) and unrelated (lanes 3,4,7,8) unlabelled 
oligos. A common retarded band was seen in lanes 1 and 5, 
indicating the presence of an ER-DNA complex. Binding of 
ER on the RAS ERE probe was abolished only in the 
presence of excess of ERE related competitors, indicating 
specific binding of estrogen receptor on the H-ras ERE. 
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Figure 3. Identification of GR-H-ras GRE complexes by specific antibody. 
Binding reaction mixtures contained 13 μg of HeLa total nuclear protein, 
0.01 pmoles of 32P labelled hMTIIA GRE and RAS GRE probes, polyclonal 
anti-human glucocorticoid receptor antibody in amounts indicated above 
each lane. Protein-DNA complexes were separated as in Fig. 2. 
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Figure 4. GR binding to GRE derived from two different cell lines. Binding 
reaction mixtures contained 0.01 pmoles of hMTIIA GRE (lanes 1-3 and 6-8) 
or RAS GRE (lanes 4,5 and 9-11) radiolabeled probe and 10,15, or 20 μg of 
nuclear protein, as indicated above the lanes. LATK" (lanes 1-5) or HeLa 
(lanes 6-11) nuclear extracts were used. Protein-DNA complexes were 
separated as in Fig. 2. 
The steroid hormone receptors are one of the most 
extensively studied group of the known regulatory factors, 
however, little is still known about hormonal regulation of 
cellular oncogenes (32,37,38). Using gel retardation assays 
we observed specific binding of hormone receptors in the li­
ra i gene, at positions which were previously predicted 
through computer scanning analysis. We showed that 
glucocorticoid receptor binds a consensus motif at position 
1261 of the conserved 3' end of the first intron of the H-ras 
and that estrogen receptor binds a sequence at position 3007, 
at the fourth intron of the gene. These results provide data for 
hormone regulation of the human H-rasl oncogene. 
Furthermore, potentially active HREs are found in sequences 
of the H-ras intron, suggesting a regulatory role for introns in 
the H-ras gene expression. Moreover, the end of the first 
intron is evolutionarily well conserved (33), suggesting a 
functional role for the H-ras GRE in human and other 
organisms as well. The existence of other possible regulatory 
elements in the vicinity of the H-ras GRE as shown in Fig. 1 
(39-41), also implies a functional role for the H-ras GRE. 
Previous data for regulation of the murine H-ras gene by 
glucocorticoids has been reported (42). The cooperation 
between glucocorticoid hormones and the T24 H-ras 
oncogene in cell transformation (43) suggests the 
involvement of the H-ras gene in hormonal promotion of 
breast tumors through abnormal hormonal regulation. In 
addition, development of breast carcinomas in rats has been 
shown to be initiated by mutations in the H-ras and K-ras 
genes and to depend on promotion by estrogens (44). The 
latency of ras oncogenes to induce cell transformation in the 
absence of hormonal stimulation (44) might be due to the 
inability of ras oncogenes to induce proliferation of the 
mammary precursor cells. Our experimental results suggest a 
more direct implication of H-ras in hormonal tumor 
promotion by proposing hormonal regulation of the H-ras 
gene (normal or mutated), also providing an explanation for 
the specificity of tumor development in systems involving 
ras genes and sexual development. 
Using ras p21 as a possible marker for the disease may be 
of prognostic significance. Depending on the way the H-ras 
gene is regulated by hormones, an explanation of indications 
correlating the levels of hormone receptors and prognosis of 
the disease may also be provided (45-47). 
In conclusion, more data on the hormone regulation of the 
H-ras gene through specific receptor binding could be 
provided by combining in vitro CAT assay experiments and 
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Figure 5. Binding of the ER to Η-ras ERE. Binding reaction mixtures 
contained 0.01 pmoies of Vitellogenin ERE (lanes 1-4) or RAS ERE 
radiolabelled probe and 20 μg of nuclear protein. Unlabelled RAS ERE (lane 
2) and Vitellogenin ERE (lane 6) probes, as well as the unrelated probes NF-
1 (lanes 3,7) and HIV-1 LTR-AP-1 (lanes 4,8) were used in competition 
experiments. Protein-DNA complexes were separated as indicated in the 
Fig. 2 legend. ER-H-ras ERE complex is indicated by the arrow. 
in vivo d e t e r m i n a t i o n of t h e ras p 2 1 l e v e l s in s t a b l e 
t r a n s f e c t a n t s , w h e n a d d i n g the c o r r e s p o n d i n g h o r m o n e . 
Moreover , compar ing the levels of the receptor b inding in 
c o r r e s p o n d i n g H R E s in h u m a n t u m o r s wi th the ad jacent 
n o r m a l t i s sues , t h r o u g h gel r e t a r d a t i o n assays , m a y g ive 
additional evidence for the role of hormonal regulation of the 
Η-ras gene in h u m a n tumor progression. 
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